West Roxbury, MA, United States of America

Shalina Mahajan-Miklos


Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2002-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shalina Mahajan-Miklos: Innovator in Infection Prevention

Introduction

Shalina Mahajan-Miklos is a prominent inventor based in West Roxbury, MA (US). She has made significant contributions to the field of infection prevention through her innovative research and patented methods. With a total of 2 patents, her work focuses on identifying compounds that can inhibit infection and pathogenicity.

Latest Patents

Her latest patents include "Methods of screening compounds useful for prevention of infection or pathogenicity," which discloses screening procedures for identifying compounds that can inhibit infection or pathogenicity. Additionally, she holds a patent titled "Virulence-associated nucleic acid sequences and uses thereof," which describes bacterial virulence polypeptides and nucleic acid sequences encoding such polypeptides. This patent also outlines methods for producing these polypeptides using recombinant techniques and for utilizing them to screen for antibacterial or bacteriostatic compounds.

Career Highlights

Throughout her career, Shalina has worked with esteemed organizations such as The General Hospital Corporation and The Netherlands Cancer Institute. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.

Collaborations

Shalina has collaborated with notable colleagues, including Frederick M Ausubel and Laurence G Rahme. These partnerships have further enriched her research and innovation in the field.

Conclusion

Shalina Mahajan-Miklos is a trailblazer in the realm of infection prevention, with her patents paving the way for new methods to combat pathogenicity. Her contributions to science and collaboration with esteemed colleagues highlight her dedication to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…